Kennedy Capital Management, Inc. Bicycle Therapeutics PLC Transaction History
Kennedy Capital Management, Inc.
- $4.35 Billion
- Q2 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 264,047 shares of BCYC stock, worth $6 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
264,047
Previous 252,172
4.71%
Holding current value
$6 Million
Previous $6.28 Million
14.89%
% of portfolio
0.12%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
111Shares Held
40.7MCall Options Held
3.4KPut Options Held
12.4K-
Baker Bros. Advisors LP New York, NY9.4MShares$213 Million2.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$79.3 Million2.32% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$51.2 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.12MShares$48.2 Million6.34% of portfolio
-
Armistice Capital, LLC New York, NY1.97MShares$44.8 Million0.52% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $674M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...